Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Injection drug use provides an efficient mechanism for transmitting bloodborne viruses, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Effective targeting of resources for prevention of HIV and HCV infection among persons who inject drugs (PWID) is based on knowledge of the population size and disparity in disease burden among PWID. This study estimated the number of PWID in the United States to calculate rates of HIV and HCV infection. METHODS: We conducted meta-analysis using data from 4 national probability surveys that measured lifetime (3 surveys) or past-year (3 surveys) injection drug use to estimate the proportion of the United States population that has injected drugs. We then applied these proportions to census data to produce population size estimates. To estimate the disease burden among PWID by calculating rates of disease we used lifetime population size estimates of PWID as denominators and estimates of HIV and HCV infection from national HIV surveillance and survey data, respectively, as numerators. We calculated rates of HIV among PWID by gender-, age-, and race/ethnicity. RESULTS: Lifetime PWID comprised 2.6% (95% confidence interval: 1.8%-3.3%) of the U.S. population aged 13 years or older, representing approximately 6,612,488 PWID (range: 4,583,188-8,641,788) in 2011. The population estimate of past-year PWID was 0.30% (95% confidence interval: 0.19 %-0.41%) or 774,434 PWID (range: 494,605-1,054,263). Among lifetime PWID, the 2011 HIV diagnosis rate was 55 per 100,000 PWID; the rate of persons living with a diagnosis of HIV infection in 2010 was 2,147 per 100,000 PWID; and the 2011 HCV infection rate was 43,126 per 100,000 PWID. CONCLUSION: Estimates of the number of PWID and disease rates among PWID are important for program planning and addressing health inequities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The proportion of candidemia patients with an IDU history is much higher than the estimated <1% of the entire U.S. population with a history of IDU during the previous 12 months (55)”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 2×
“5% population proportion of PWID in Puerto Rico, Puerto Rico population totals from census data [16], and the estimated number of PWID living with diagnosed HIV infection in Puerto Rico in 2010 from CDC’s HIV case surveillance data [5].”
BackgroundMethodFixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977 · cited 1×
“We selected random effects models for our analyses because the models assume the studies are a random sample [15], a type of inference that fits the purpose of our study.”
MethodThe Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Self-citationLyons, S. J., Johnson, A. S., Hu, X., Yu, C., Jin, C., Wu, B., Li, J., Chong, M., Hawkins, D., Wang, S., et al. (2017) · Cited by 636
Mohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.
Holmberg, S. D. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.642 · Cited by 539 · cited 1×
“PWID among the nation as a whole and for large metropolitan areas [7–10].”
Background
Cited by
Items 201–239 of 239
El‐Bassel, N., Marotta, P. L., Gilbert, L., Wu, E. Y., Springer, S. A., Goddard‐Eckrich, D., & Hunt, T. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190675486.003.0008 · Cited by 2
Opioid abuse surveillance in patients with endocarditis
Jatis, A. J., Stafford, S. R., Coyle, R. O., Karlan, N., Miller, A. C., & Polgreen, L. A. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.07.014 · Cited by 1
Viral Hepatitis C Infection Among Injecting Drug Users and their Partners in Manipur
Singh, K. R., Dhabali, T., Akoijam, B. S., & Nalinikanta, R. (2021) · Journal of Medical Evidence · doi:10.4103/jme.jme_184_20 · Cited by 1
Yin, S., Ly, K. N., Barker, L. K., Bixler, D., Thompson, N. D., & Gupta, N. (2024) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000002014 · Cited by 1
Kahn, J. G., Bendavid, E., Dietz, P. M., Hutchinson, A. B., Horváth, H., McCabe, D., & Wolitski, R. J. (2020) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325958220950902 · Cited by 1
“The number of HIV tests required by risk group and setting (Table 1) begins with the population size of each risk group, as provided in demographic reports of population statistics for the general population and high-risk group sizes ages 15–44.(15-18) (Each table entry is precisely cited and detailed in an online Tec…”
BackgroundOn the Wrong Side of the Tracks?: Ethical Considerations of the Needle Black Market
Panariello, N. (2016) · Elements · doi:10.6017/eurj.v12i1.9296
A Public Health of Consequence: Review of the July 2017 Issue of AJPH
Galea, S., & VAUGHAN, R. D. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303868
HENEGHAN, C. P. H. (2015) · OpenCommons - UConn (University of Connecticut)
ADDRESSING BARRIERS TO HEPATITIS C TREATMENT INITIATION IN KENTUCKY CLINIC
Abdelwadoud, M. (2017) · UKnowledge (University of Kentucky)
Shinefeld, J. (2017) · TUScholarShare (Temple University)
CLINICAL FACTORS ASSOCIATED WITH HEPATITIS C TREATMENT SELECTION IN A VETERANS AFFAIRS POPULATION
Ranson, C. A. (2017) · Scholarly Commons (University of the Pacific)
Event-Level Substance Use and Unprotected Sex among Young Adults: A Case-Crossover Analysis
Muchimba, M. (2017) · Austin Journal of HIV/AIDS Research · doi:10.26420/austinjhivaidsres.2017.1034
West Virginia needle exchange program
Washington, B., & Johnson, S. M. (2017)
Breslau, J. A., McBain, R. K., & Simmons, M. M. (2019) · RAND Corporation eBooks · doi:10.7249/rr2724
Leopold, S. S. (2018) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000000381
“6% [4] and the biggest limitation of this manuscript is that it likely underestimates the scope of the”
BackgroundLatina Injection Drug Users: A Descriptive Analysis of an Overlooked Population in South Florida
Shehadeh, N., Sánchez, J., & Rubens, M. (2019) · NSUWorks (Nova Southeastern University)
The Opioid Epidemic: Associated Infections and Diagnostic Methods
Lloyd, M., & Farnsworth, C. W. (2020) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2020.08.003
The case of Scott County: injection drug use and the HIV and hepatitis C virus outbreak
Cafardi, J. M., & Feinberg, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-68328-9.00002-3
Injury, Infection, and Recovery from Opioid Use Disorders in Michigan
Gicquelais, R. E. (2018) · Deep Blue (University of Michigan)
Epidemiology of Injection Drug Use among Teenagers Infected with HIV and Hepatitis in the US
Sanyaolu, A. O. (2021) · Journal of Infectious Diseases & Travel Medicine · doi:10.23880/jidtm-16000145
Singh, A., Kumar, M., Singh, A. K., & Verma, N. (2022) · Reviews on Recent Clinical Trials · doi:10.2174/1574887117666220817123002
Thomas, T. (2021) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3741
A Note on Preexposure Prophylaxis Preferences Among Women Who Inject Drugs
Miley, K. L., Tran, N. K., Elopre, L. E., Groves, A. K., Stockman, J. K., Bazzi, A. R., Carrico, A. W., Mazzella, S., & Roth, A. M. (2023) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001768
Needle exchange programs and their impact on HIV incidence in West Virginia: Is it working?
Graves, A., Duty, K., Norton, T., & Coustasse, A. (2023) · International Journal of Healthcare Management · doi:10.1080/20479700.2023.2255772
“There have also been studies that have proven that needle exchange programs have been cost-e ff ective compared to treating a patient with HIV [15,16].”
Evans, K. N., WORTLEY, P. M., Gandhi, A. P., & Bradley, H. M. (2023) · Public Health Reports · doi:10.1177/00333549231205341
“Although most new HCV infections in the United States are attributable to IDU, 7,23,28 condomless anal sex also increases the risk of HCV infection among MSM, 11,29-32 making MSM another often overlooked priority population for routine HCV testing and other prevention interventions.”
HIV/AIDS: Ethical and Legal Aspects
Loue, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-12128-9.00036-x
Gu, M., Martinez, R. G., Parent, H., Marshall, B. D. L., Berk, J., Elwy, A. R., Chan, P. A., & Tao, J. (2025) · Implementation Science Communications · doi:10.1186/s43058-025-00782-1 · Cited by 1
“An estimated 2.6% of the US population has a history of injection drug use, further underscoring the importance of studying links between OUD and HIV [2].”
InfluentialAnton, A. (2025) · Journal of Appalachian Studies · doi:10.5406/23288612.31.2.02
Chiosi, J. J., Mueller, P. P., Chhatwal, J., & Ciaranello, A. L. (2023) · Figshare · doi:10.6084/m9.figshare.23700557
Ohringer, A. R., Serota, D. P., McLean, R., Stockman, L. J., & Watt, J. P. (2021) · Figshare · doi:10.6084/m9.figshare.15032995
Annarumo, C. (2019) · D-Scholarship@Pitt (University of Pittsburgh)
Washington Jr, W. J. (2019) · ScholarWorks (Walden University)
Bovell-Ammon, B. J., Onofrey, S., Kimmel, S. D., Wurcel, A. G., & Klevens, R. M. (2026) · BMC Public Health · doi:10.1186/s12889-026-26437-x
Mauricio, A. M., Cioffi, C. C., Gau, J. M., Fernandes, L., Cil, G., Sanders, A. M., Pope, K., & Josi, K. M. (2026) · American Journal of Health Promotion · doi:10.1177/08901171261438386
Drug Use and Social Connectivity Related to Hepatitis C Infection Among Rural People Who Use Drugs
Rains, A., Almirol, E. A., Nicholson, W., Fletcher, S., Jenkins, W. D., Schneider, J. A., & Pho, M. T. (2026) · Journal of Viral Hepatitis · doi:10.1111/jvh.70200
Geissert, P. (2026) · PDXScholar (Portland State University)
Infections and the Opioid Epidemic: Changing Epidemiology and Treatment Options
Fanucchi, L. C., Eaton, E., Sickels, N. J. V., & Lofwall, M. R. (2026) · Drugs · doi:10.1007/s40265-026-02364-4
“As of 2018, an estimate of approximately 1.5% of the US adult population or ~ 3.7 million people injected drugs, which is more than 5 times the estimate from 2011 of ~ 774,000 [26,27].”
Influential
Metadata
- Authors
- Lansky, A., Finlayson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., Gust, D., Chen, R., Mizuno, Y., & Crepaz, N.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Lansky, Amy
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-05-19
- Volume
- 9
- Issue
- 5
- Pages
- e97596
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4026524
- OpenAlex
- W1996627792
- Cited by
- 235
- References
- 23
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 15 · 2022: 8 · 2021: 31 · 2020: 36 · 2019: 24 · 2018: 26 · 2017: 30 · 2016: 20 · 2015: 24 · 2014: 1
- FWCI
- 18.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- people who inject drugs, HIV infection rates, population size estimation, HIV surveillance, health disparities, United States
- MeSH terms
- Adolescent, Adult, Female, Hepatitis C, Humans, Male, Middle Aged, United States, HIV Infections, Substance Abuse, Intravenous, Drug Users, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
